col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


99 Results       Page 1

 [1] 
Elsevier: Journal of Clinical Epidemiology
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 Reporting of Health Equity Considerations in Vaccine Trials for COVID-19: Comment Hinpetch Daungsupawong, Viroj Wiwanitkit
2 [GO] 2024―Mar―04 Reporting of Health Equity Considerations in Vaccine Trials for COVID-19: A Methodological Review Roger Kou, Sarah Lopes Sadafi, Rachael Principato, Laura N. Anderson, Romina Brignardello-Petersen, Lawrence Mbuagbaw
3 [GO] 2024―Feb―02 External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting Anum Zahra, Maarten van Smeden, Evertine J. Abbink, Jesse M. van den Berg, Marieke T. Blom, Carline J. van den Dries, et al. (+12)
4 [GO] 2024―Feb―01 Estimates of sensitivity and specificity of serological tests for SARS-CoV-2 specific antibodies using a Bayesian latent class model approach Joana P. Costa, Paula Meireles, Eleftherios Meletis, Polychronis Kostoulas, Milton Severo
5 [GO] 2024―Feb―01 Using the GRADE Evidence to Decision Framework to reach recommendations together with ethnic minority community organisations: the example of COVID-19 vaccine uptake in the UK Shaun Treweek, Miriam Brazzelli, Annette Crosse, Sunil Daga, Talia Isaacs, Ria Sunga
6 [GO] 2024―Jan―23 The reporting completeness and transparency of systematic reviews of prognostic prediction models for COVID-19 was poor: a methodological overview of systematic reviews. Persefoni Talimtzi, Antonios Ntolkeras, Georgios Kostopoulos, Konstantinos I. Bougioukas, Eirini Pagkalidou, Andreas Ouranidis, et al. (+2)
7 [GO] 2024―Jan―17 The total effect of ethnicity on COVID-19 outcomes is underestimated when conditioning for comorbidities: Response to Learoyd et al Fredi Alexander Diaz-Quijano, Luís Ricardo Santos de Melo
8 [GO] 2024―Jan―17 The complexity of the relationship between ethnicity and Covid-19 outcomes: author’s reply Annastazia E. Learoyd, Jennifer Nicholas, Abdel Douiri
9 [GO] 2023―Dec―09 Exploring the use and impact of the Australian living guidelines for the clinical care of people with COVID-19: Where to from here? Tanya Millard, Julian H. Elliotta, Sally Greena, Steve McGloughlina, Tari Turnera
10 [GO] 2023―Dec―08 Clinical and methodological implications for research elements in systematic reviews on COVID-19 treatment were often unstructured and underreported - a meta-research study W. Siemens, G. Bantle, S. Mahler, J. Nothacker, J. Stadelmaier, E.M. Bitzer, et al. (+2)
11 [GO] 2023―Aug―25 No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study Mauricia Davidson, Theodoros Evrenoglou, Carolina Graña, Anna Chaimani, Isabelle Boutron
12 [GO] 2023―Aug―09 Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study Omar Dewidar, Mostafa Bondok, Leenah Abdelrazeq, Khadija Aliyeva, Karla Solo, Vivian Welch, et al. (+28)
13 [GO] 2023―Jun―28 Revisiting ethnic discrepancies in Covid-19 hospitalised cohorts: a correction for collider bias Annastazia E. Learoyd, Jennifer Nicholas, Nicholas Hart, Abdel Douiri
14 [GO] 2023―May―02 Validity of prognostic models of critical COVID-19 is variable. A systematic review with external validation Gabriela Cárdenas-Fuentes, Magda Bosch de Basea, Inés Cobo, Isaac Subirana, Mario Ceresa, Ernest Famada, et al. (+9)
15 [GO] 2023―Mar―24 COVID-19 trials were not more likely to report intent to share individual data than non-COVID-19 trials in ClinicalTrials.gov Bruno Ramdjee, Mathilde Husson, David Hajage, Florence Tubach, Candice Estellat, Agnès Dechartres
16 [GO] 2023―Mar―03 Non-drug interventions for reducing SARS-CoV-2 transmission are frequently incompletely reported Sharon Sanders, Elizabeth Gibson, Paul Glasziou, Tammy Hoffmann
17 [GO] 2023―Feb―20 Weekly updating of guideline recommendations was feasible: the Australian National COVID-19 Clinical Evidence Taskforce Jessie Hewitt, Steve McDonald, Alex Poole, Heath White, Simon Turner, Tari Turner
18 [GO] 2023―Feb―16 Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety Lars Christian Lund, Henrik Støvring, Anton Pottegård, Morten Andersen, Jesper Hallas
19 [GO] 2022―Dec―14 Minimal reporting improvement after peer review in reports of covid-19 prediction models: systematic review Mohammed T. Hudda, Lucinda Archer, Maarten van Smeden, Karel G.M. Moons, Gary S. Collins, Ewout W. Steyerberg, et al. (+5)
20 [GO] 2022―Nov―17 NON-INTERVENTIONAL STUDIES IN THE COVID-19 ERA: METHODOLOGICAL CONSIDERATIONS FOR STUDY DESIGN AND ANALYSIS Anne M. Butler, Mehmet Burcu, Jennifer B. Christian, Fang Tian, Kathleen M. Andersen, William A. Blumentals, et al. (+2)
21 [GO] 2022―Oct―27 Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort Daniek A.M. Meijs, Sander M.J. van Kuijk, Laure Wynants, Björn Stessel, Jannet Mehagnoul-Schipper, Anisa Hana, et al. (+26)
22 [GO] 2022―Oct―20 Understanding how deferred consent affects patient characteristics and outcome: an exploratory analysis of a clinical trial of prone positioning for COVID-19 Michael Colacci, Afsaneh Raissi, Ajay Bhasin, Leora Branfield Day, Melissa Bregger, Travis Carpenter, et al. (+20)
23 [GO] 2022―Oct―18 How pragmatic are randomized trials of Remdesivir and Favipiravir for in-hospital treatment of Covid-19: A descriptive methodological review of trial design using the PRECIS-2 framework Tanmay Sharma, Intisar Qamar, Merrick Zwarenstein
24 [GO] 2022―Oct―06 The relationship between pragmatism, timing, and study size on impact of treatment trials: a qualitative, hypothesis generating study of systemic corticosteroids for COVID-19 Aileen Liang, Katrina Domenica Cirone, Xiaoxiao (Daisy) Deng, Merrick Zwarenstein
25 [GO] 2022―Oct―06 Evidence, values & masks for control of COVID-19: two years later Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt
26 [GO] 2022―Sep―27 Three out of four published systematic reviews on COVID-19 treatments were not registered and one third of those registered were published: a meta-research study Waldemar Siemens, Julia Nothacker, Julia Stadelmaier, Jörg J. Meerpohl, Christine Schmucker
27 [GO] 2022―Aug―18 Thromboprophylaxis with standard- vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation Gonzalo Martínez-Alés, Arce Domingo-Relloso, Manuel Quintana-Díaz, Carmen Fernández-Capitán, Miguel A. Hernán
28 [GO] 2022―Aug―04 Systematic reviews of convalescent plasma in COVID-19 continue to be poorly conducted and reported: a systematic review. Rebecca Whear, Alison Bethel, Rebecca Abbott, Morwenna Rogers, Noreen Orr, Sean Manzi, et al. (+3)
29 [GO] 2022―Jul―20 Gastrointestinal prophylaxis for COVID-19: An illustration of severe bias arising from inappropriate comparators in observational studies Kueiyu Joshua Lin, William B. Feldman, Shirley Wang, Siddhi Pramod Pramod Umarje, Elvira D'Andrea, Helen Tesfaye, et al. (+3)
30 [GO] 2022―Jul―19 Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: Results from the COVID-19 Evidence Network to support Decision-making (COVID-END) Michael McCaul, David Tovey, Taryn Young, Vivian Welch, Omar Dewidar, Mireille Goetghebeur, et al. (+9)
31 [GO] 2022―Jul―02 HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study Thokozani Kalua, Matthias Egger, Andreas Jahn, Tiwonge Chimpandule, Rose Kolola, Nanina Anderegg
32 [GO] 2022―May―28 Toward an observatory of the evolution of clinical trials through phylomemy reconstruction: the COVID-19 vaccines example Quentin Lobbé, David Chavalarias, Alexandre Delanoë, Gabriel Ferrand, Sarah Cohen-Boulakia, Philippe Ravaud, Isabelle Boutron
33 [GO] 2022―May―19 COVID-19 L·OVE repository is highly comprehensive and can be used as a single source for COVID-19 studies F. Verdugo-Paiva, C. Vergara, C. Ávila, J. Castro, J. Cid, V. Contreras, et al. (+12)
34 [GO] 2022―May―02 Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study Juan R. Tercero-Hidalgo, Khalid S. Khan, Aurora Bueno-Cavanillas, Rodrigo Fernández-López, Juan F. Huete, Carmen Amezcua-Prieto, et al. (+2)
35 [GO] 2022―Apr―30 A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 Recommendation Map Kevin Pottie, Maureen Smith, Micayla Matthews, Nancy Santesso, Olivia Magwood, Tamara Kredo, et al. (+23)
36 [GO] 2022―Apr―06 High-cited favorable studies for COVID-19 treatments ineffective in large trials John P.A. Ioannidis
37 [GO] 2022―Mar―30 Using Explicit Thresholds for Benefits and Harms in partially contextualized GRADE Guidelines. Pilot experience from a living COVID-19 guideline Ignacio Neumann, Eduardo Quiñelen, Paula Nahuelhual, Pamela Burdiles, Natalia Celedón, Katherine Cerda, et al. (+8)
38 [GO] 2022―Mar―25 The currency and completeness of specialized databases of COVID-19 publications Robyn Butcher, Margaret Sampson, Rachel J. Couban, James Edward Malin, Sara Loree, Stacy Brody
39 [GO] 2022―Feb―25 COVID-19 scenarios for a long-term strategy under fundamental uncertainty Frans Brom, Josta de Hoog, J. André Knottnerus, Ruth Mampuys, Tanja van der Lippe
40 [GO] 2022―Feb―19 Most published systematic reviews of remdesivir for COVID-19 were redundant and lacked currency Steve McDonald, Simon Turner, Matthew J Page, Tari Turner
41 [GO] 2022―Jan―15 Evidence suggests that SARS-CoV-2 rapid antigen tests provide benefits for epidemic control - observations from Austrian schools Jitka Polechová, Kory D. Johnson, Pavel Payne, Alex Crozier, Mathias Beiglböck, Pavel Plevka, Eva Schernhammer
42 [GO] 2021―Dec―26 A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile Marcela Zuñiga, Anne J Lagomarcino, Sergio Muñoz, Alfredo Peña Alonso, María Andrea Rodriguez, Miguel L O'Ryan
43 [GO] 2021―Dec―18 Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results. Ariel Izcovich, Sasha Peiris, Martín Ragusa, Fernando Tortosa, Gabriel Rada, Sylvain Aldighieri, Ludovic Reveiz
44 [GO] 2021―Dec―14 COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices Zijun Wang, Hui Liu, Yang Li, Xufei Luo, Nan Yang, Meng Lv, et al. (+14)
45 [GO] 2021―Nov―28 Awareness, Value and Use of the Australian living guidelines for the clinical care of people with COVID-19: An Impact Evaluation Tanya Millard, Julian H Elliott, Sally Green, Britta Tendal, Joshua P. Vogel, Sarah Norris, et al. (+2)
46 [GO] 2021―Nov―14 The methodology of a “living” COVID-19 registry development in a clinical context Chiara Arienti, Silvia Campagnini, Lorenzo Brambilla, Chiara Fanciullacci, Stefano Giuseppe Lazzarini, Andrea Mannini, et al. (+2)
47 [GO] 2021―Nov―14 International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review Yasser S. Amer, Maher A. Titi, Mohammad Wefqy Godah, Hayfaa A. Wahabi, Layal Hneiny, Manal Mohamed Abouelkheir, et al. (+23)
48 [GO] 2021―Nov―13 Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions Ivan D. Florez, Yasser Sami Amer, Michael McCaul, John N Lavis, Melissa Brouwers
49 [GO] 2021―Nov―13 Many Trials of Hydroxychloroquine for SARS-CoV-2 Were Redundant and Potentially Unethical: An Analysis of the NIH Clinical Trials Registry Vignan Yogendrakumar, Brian Dewar, Michaeline McGuinty, Dar Dowlatshahi, Claire Dyason, Edmond SH Kwok, et al. (+3)
50 [GO] 2021―Oct―28 Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review Hanan Khalil, Lotfi Tamara, Gabriel Rada, Elie A. Akl
51 [GO] 2021―Oct―27 Change in healthcare during Covid-19 pandemic was assessed through observational designs Giovanni Corrao, Anna Cantarutti, Matteo Monzio Compagnoni, Matteo Franchi, Federico Rea
52 [GO] 2021―Oct―27 Estimating total morbidity burden of COVID-19: relative importance of death and disability Maia P. Smith
53 [GO] 2021―Sep―20 Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19. O Pierre, C Riveros, S Charpy, I Boutron
54 [GO] 2021―Sep―12 Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper Claire Iannizzi, Elena Dorando, Jacob Burns, Stephanie Weibel, Clare Dooley, Helen Wakeford, et al. (+3)
55 [GO] 2021―Aug―03 Evaluating tests for diagnosing COVID-19 in the absence of a reliable reference standard: pitfalls and potential solutions Daniël A. Korevaar, Julie Toubiana, Martin Chalumeau, Matthew D.F. McInnes, Jérémie F. Cohen
56 [GO] 2021―Jul―18 COVID-19 and the Future of Clinical Epidemiology Katrina Armstrong, Ralph Horwitz
57 [GO] 2021―Jul―15 Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining Kimia Honarmand, Jeremy Penn, Arnav Agarwal, Reed Siemieniuk, Romina Brignardello-Petersen, Jessica J. Bartoszko, et al. (+13)
58 [GO] 2021―Jul―13 Ethics of COVID-19 vaccine trials in rapidly changing contexts J. André Knottnerus
59 [GO] 2021―Jul―13 Placebo-controlled trials with COVID-19 vaccines: participants first Rafael Dal-Ré
60 [GO] 2021―Jul―03 Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin Dongguang Wang, Lingmin Chen, Lian Wang, Fang Hua, Juan Li, Yuxi Li, et al. (+4)
61 [GO] 2021―Jun―11 ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19 Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Mayte Pérez-Olmeda, Miguel A Hernán, Jesús Oteo-Iglesias, Nerea Fernández de Larrea, et al. (+10)
62 [GO] 2021―Jun―02 A systematic review that is "rapid" and "living": a specific answer to the COVID-19 pandemic S Negrini, Ceravolo MG, P Côté, C Arienti
63 [GO] 2021―May―25 Randomized COVID-19 vaccination rollout can offer direct real-world evidence Lars G. Hemkens, Steven N. Goodman
64 [GO] 2021―May―25 Allocation of Scarce Resources in a Pandemic: Rapid Systematic Review Update of Strategies for Policy Makers S Hempel, RV Burke, M Hochman, G Thompson, A Brothers, J Shin, et al. (+5)
65 [GO] 2021―May―19 Using Preprints in Evidence Synthesis: Commentary on experience during the COVID-19 pandemic Barbara Clyne, Kieran A. Walsh, Eamon O'Murchu, Melissa K. Sharp, Laura Comber, Kirsty K O’ Brien, et al. (+5)
66 [GO] 2021―Apr―21 COVID-19 and the research scholarship ecosystem: help! David Moher
67 [GO] 2021―Apr―06 Getting trustworthy guidelines into the hands of global decision-makers and supporting their consideration of contextual factors for implementation: recommendation mapping of COVID-19 guidelines Tamara Lotfi, Adrienne Stevens, Elie A. Akl, Maicon Falavigna, Tamara Kredo, Joseph L. Mathew
68 [GO] 2021―Mar―27 Effect Estimates of COVID-19 Non-Pharmaceutical Interventions are Non-Robust and Highly Model-Dependent Vincent Chin, John P.A. Ioannidis, Martin A. Tanner, Sally Cripps
69 [GO] 2021―Mar―26 A meta-research study revealed susceptibility of Covid-19 treatment research to white hat bias: First, do no harm Ioannis Bellos
70 [GO] 2021―Mar―18 “NEVER LET A CRISIS GO TO WASTE”: HOW SCIENCE HAS RESPONDED TO THE COVID-19 PANDEMIC Peter Tugwell, David Tovey, Carlos A. Cuella-Garcia
71 [GO] 2021―Mar―18 New placebo-controlled Covid-19 vaccine trials are ethically questionable; it's now about comparative effectiveness and availability of registered vaccines J. André Knottnerus
72 [GO] 2021―Mar―09 Will COVID-19 result in a giant step backwards for women in academic science? Larissa Shamseer, Ivy Bourgeault, Eva Grunfeld, Ainsley Moore, Nazia Peer, Sharon E. Straus, Andrea C. Tricco
73 [GO] 2021―Mar―07 The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review Tanja A Stamm, Margaret R Andrews, Erika Mosor, Valentin Ritschl, Linda C Li, Jasmin K Ma, et al. (+17)
74 [GO] 2021―Mar―01 Vancouver Coastal Health informed COVID-19 response by applying rapid review methodology: Reply to Tricco. Linda Dix-Cooper, Martin Dawes, Mina Park
75 [GO] 2021―Feb―28 Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping Yanfei Li, Liujiao Cao, Ziyao Zhang, Liangying Hou, Yu Qin, Xu Hui, et al. (+8)
76 [GO] 2021―Feb―03 Double-zero-event studies matter: a re-evaluation of physical distancing, face masks, and eye protection for preventing person-to-person transmission of COVID-19 and its policy impact Mengli Xiao, Lifeng Lin, James S. Hodges, Chang Xu, Haitao Chu
77 [GO] 2020―Dec―07 The COVID-19 pandemic and a reflection on the conduction of clinical trials in times of war Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Rachel Riera
78 [GO] 2020―Dec―07 Modeling the COVID-19 Pandemic: A Comprehensive Guide of Infectious Disease and Decision-Analytic Models Stephen Mac, Sharmistha Mishra, Raphael Ximenes, Kali Barrett, Yasin A. Khan, David Naimark, Beate Sander
79 [GO] 2020―Dec―01 Evidence, values & masks for control of COVID-19 Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt
80 [GO] 2020―Nov―20 COVID-19, health inequities, and methodology’s mission J. André Knottnerus, Peter Tugwell
81 [GO] 2020―Nov―11 Weekly updates of national living evidence-based guidelines: Methods for the Australian Living Guidelines for Care of People with COVID-19 Britta Tendal, Joshua P. Vogel, Steve McDonald, Sarah Norris, Miranda Cumpston, Heath White, et al. (+10)
82 [GO] 2020―Oct―21 Research response to COVID-19 needed better coordination and collaboration: a living mapping of registered trials Van Thu Nguyen, Philippe Rivière, Pierre Ripoll, Julien Barnier, Romain Vuillemot, Gabriel Ferrand, et al. (+63)
83 [GO] 2020―Oct―14 Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive Michael Ewers, John P.A. Ioannidis, Nikolaus Plesnila
84 [GO] 2020―Sep―30 The impact of the coronavirus disease of 2019 on research. Dr. Najla F. Alsiri, Dr. Meshal A. Alhadhoud, Shea Palmer
85 [GO] 2020―Sep―23 Integrating Travel History via Big Data Analytics Under Universal Healthcare Framework for Disease Control and Prevention in the COVID-19 Pandemic Kevin Sheng-Kai Ma, Shin-Yi Tsai
86 [GO] 2020―Jul―03 The Importance of Publishing Non-COVID-19 Research during COVID-19 Alexander Chaitoff
87 [GO] 2020―Jul―03 Testing COVID-19 tests faces methodological challenges Patrick M. Bossuyt
88 [GO] 2020―Jul―01 Open Synthesis and the coronavirus (COVID-19) pandemic in 2020 Neal R. Haddaway, Elie A. Akl, Matthew J. Page, Vivian A. Welch, Ciara Keenan, Tamara Lotfi
89 [GO] 2020―Jun―30 Rapid review methods more challenging during COVID-19: Commentary with a focus on 8 knowledge synthesis steps Andrea C. Tricco, Chantelle M. Garritty, Leah Boulos, Craig Lockwood, Michael Wilson, Jessie McGowan, et al. (+16)
90 [GO] 2020―Jun―27 Social Media can have an impact on how we manage and investigate the COVID-19 pandemic Carlos Cuello-Garcia, Giordano Pérez-Gaxiola, Ludo van Amelsvoort
91 [GO] 2020―Jun―12 Pandemics and methodological developments in epidemiology history Alfredo Morabia
92 [GO] 2020―Jun―09 A framework for identifying and mitigating the equity harms of COVID-19 policy interventions Rebecca E. Glover, May CI. van Schalkwyk, Elie A. Akl, Elizabeth Kristjannson, Tamara Lotfi, Jennifer Petkovic, et al. (+4)
93 [GO] 2020―Jun―08 A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis Ali A. Nasrallah, Sarah H. Farran, Zainab A. Nasrallah, Mohamad A. Chahrour, Hamza A. Salhab, Mohammad Y. Fares, et al. (+2)
94 [GO] 2020―Jun―06 Using GRADE in situations of emergencies and urgencies: Certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what Holger J. Schünemann, Nancy Santesso, Gunn E. Vist, Carlos Cuello, Tamara Lotfi, Signe Flottorp, et al. (+5)
95 [GO] 2020―May―25 ‘One more time’: why replicating some syntheses of evidence relevant to COVID-19 makes sense Matthew J. Page, Vivian A. Welch, Neal R. Haddaway, Sathya Karunananthan, Lara J. Maxwell, Peter Tugwell
96 [GO] 2020―Apr―27 Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted) Farhad Shokraneh, Tony Russell-Rose
97 [GO] 2020―Apr―23 Methodological challenges in studying the COVID-19 pandemic crisis J. André Knottnerus, Peter Tugwell
98 [GO] 2020―Apr―22 COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine Paul Elias Alexander, Victoria Borg Debono, Manoj J. Mammen, Alfonso Iorio, Komal Aryal, Dianna Deng, et al. (+2)
99 [GO] 2020―Apr―21 Reply to letter to the editor ‘Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry Barbara Nussbaumer-Streit, Irma Klerings, Gerald Gartlehner
 [1] 

99 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec